Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quadrivalent HPV Vaccination After Effective Treatment of Anal Intraepithelial Neoplasia in HIV+ Men

NCT02087384 is registered in ClinicalTrials.gov with Prof. Jan Prins as lead sponsor.

NCT NCT02087384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02087384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quadrivalent HPV Vaccination After Effective Treatment of Anal Intraepithelial Neoplasia in HIV+ Men
Lead sponsor
Prof. Jan Prins
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2014
Completion date
February 28, 2019
Enrollment
126 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ain, hiv